Targeted Treatment of Common Human Diseases With Glutathione

Abstract

Glutathione (GSH) is a typical medication and health product. Previous research has shown that GSH, which has substantial antioxidant activity, is involved in a number of crucial intracellular metabolic activities. By decreasing oxidative stress, disorders like tumors, alcoholic liver disease, and IRI can be somewhat improved. This research will examine the clinical management of heart, ocular, liver and skin illnesses, with GSH serving as the narrative focus. The association between coronary heart disease and oxidative stress was revealed by the fluorescence detection of GSH and OPA, and the amelioration of some coronary atherosclerosis by GSH was suggested. Additionally, GSH can successfully prevent surgical damage brought on by valve surgery and I/R and preserve the cardiac muscle during the procedure. For people with early cataracts, GSH eye drops are crucial, and they are more effective than oral vitamins and smoke tablets. GSH has been shown to significantly minimize problems in early and middle stage individuals with chronic hepatitis B. GSH is fairly developed in terms of skin conditions and aesthetics. Melasma can be reduced, whitened, and controlled through intravenous injection and oral means.